Keyphrases
Anti-HIV Drugs
75%
Cell Delivery System
20%
Combined Antiretroviral Therapy (cART)
30%
Conventional Drugs
20%
Disease-specific Mortality
15%
Drug Delivery
75%
Drug Formulation
20%
Epithelial Cells
15%
Extended Period
5%
Gastrointestinal Tract
15%
Gut-associated Lymphoid Tissue
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
30%
Leading Causes of Death
15%
Low-resource Countries
20%
Lymphatic Tissue
20%
M Cells
25%
Microfold Cells
95%
Micromolecules
20%
Mucosal Immune Response
15%
Nanocarriers
15%
Nanodrug
40%
Nanomedicine
20%
Pluronic
20%
Priority Research Areas
5%
Specific Antibodies
15%
Targeted Drug Delivery
15%
Therapeutic Levels
20%
Tissue Reservoirs
20%
Transcytosis
10%
Viral Reservoir
5%
Virus
15%
Medicine and Dentistry
Anti-Human Immunodeficiency Virus
100%
Antibodies
12%
Antiretroviral Therapy
24%
Disease
12%
Epithelial Cell
12%
Gastrointestinal Tract
16%
Gut-Associated Lymphoid Tissue
100%
Human Immunodeficiency Virus 1
33%
Lymphatic Tissue
12%
Microfold Cell
100%
Mucosal Immune System
16%
Nanocarrier
16%
Nanomedicine
16%
Pharmacotherapy
12%
Poloxamer
16%
Transcytosis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Human Immunodeficiency Virus
75%
Antibodies
24%
Disease
24%
Drug Formulation
33%
Human Immunodeficiency Virus 1
50%
Nanocarrier
24%
Nanomedicine
33%
Pharmacotherapy
24%
Poloxamer
33%
Targeted Drug Delivery
24%
Transcytosis
16%